v3.22.2.2
Unaudited Condensed Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities    
Net loss $ (53,896) $ (87,893)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 16,187 11,604
Amortization of right-of-use assets 1,290 0
Amortization of debt issuance costs 170 1,335
Amortization of prior hedge effectiveness 0 3,095
Impairment of other equity securities 170 0
Impairment of long-lived assets 237 872
Loss on debt extinguishment 0 7,955
Discontinuance of interest rate swaps and write-off of prior hedge effectiveness 0 8,688
Stock-based compensation 64,490 86,725
Deferred income taxes 166 (7,218)
Change in fair value of financial guarantee 0 (150)
Change in fair value of derivative instruments 0 392
Change in fair value of other equity security 0 (1,031)
Change in fair value of contingent consideration (150) 0
Unrealized foreign exchange loss 5,958 1,002
Other (1) 4
Changes in operating assets and liabilities, net of effects of business combination:    
Accounts receivable (2,902) (3,040)
Prepaid expenses and other current assets (560) (5,562)
Other assets (864) (2,283)
Accounts payable (6,417) 14,635
Accrued expenses and other liabilities 7,606 7,416
Operating lease liabilities (1,599) 0
Income tax payable 22 (368)
Deferred revenue 22,108 23,978
Net cash provided by operating activities 52,015 60,156
Cash flows from investing activities    
Acquisition, net of cash acquired (2,532) 0
Proceeds from acquisition working capital adjustment 307 0
Purchase of property and equipment (16,441) (8,500)
Payment upon extinguishment of interest rate swaps 0 (3,283)
Net cash used in investing activities (18,666) (11,783)
Cash flows from financing activities    
Repayment of capital lease obligations 0 (24)
Payment of debt issuance costs 0 (767)
Repayment of 2018 Term Loan 0 (524,300)
Repayment of hybrid debt 0 (1,332)
Payment upon extinguishment of hybrid debt 0 (9,774)
Payment of contingent consideration (600) (1,049)
Payment of special dividends 0 (115)
Proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commissions 0 581,833
Proceeds from private placement, net of underwriting discounts and commissions 0 85,050
Payment of stock issuance costs 0 (5,634)
Repurchase of common stock (61,736) (1,462)
Shares surrendered for settlement of minimum statutory tax withholding (41) 0
Proceeds from issuance of stock under employee stock plans 1,682 412
Net cash (used in) provided by financing activities (60,695) 122,838
Effect of exchange rate changes on cash and cash equivalents (139) 23
Net (decrease) increase in cash and cash equivalents, and restricted cash equivalents (27,485) 171,234
Cash and cash equivalents, and restricted cash equivalents, at beginning of the period 239,297 139,470
Cash and cash equivalents at end of the period 211,812 310,704
Non-cash investing and financing activities:    
Conversion of Series A redeemable convertible preferred stock into common stock in connection with initial public offering 0 70,906
Purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities 1,124 486
Change in fair value of hedged interest rate swaps and interest rate cap 0 (5,817)
Capitalized stock-based compensation 1,779 35
Right-of-use assets under operating leases 13,165 0
Contingent consideration for acquired business $ 850 $ 0